APA

Piccart M. J., Bertelsen K., Stuart G., Cassidy J., Mangioni C., Simonsen E., James K., Kaye S., Vergote I., Blom R., Grimshaw R., Atkinson R., Swenerton K., Trope C., Nardi M., Kaern J., Tumolo S., Timmers P., Roy J., Lhoas F., Lidvall B., Bacon M., Birt A., Andersen J., Zee B., Paul J., Pecorelli S., Baron B. & McGuire W. (20040408). Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Chicago

Piccart M J, Bertelsen K, Stuart G, Cassidy J, Mangioni C, Simonsen E, James K, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson R, Swenerton K, Trope C, Nardi M, Kaern J, Tumolo S, Timmers P, Roy J-A, Lhoas F, Lidvall B, Bacon M, Birt A, Andersen J, Zee B, Paul J, Pecorelli S, Baron B and McGuire W. 20040408. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Harvard

Piccart M. J., Bertelsen K., Stuart G., Cassidy J., Mangioni C., Simonsen E., James K., Kaye S., Vergote I., Blom R., Grimshaw R., Atkinson R., Swenerton K., Trope C., Nardi M., Kaern J., Tumolo S., Timmers P., Roy J., Lhoas F., Lidvall B., Bacon M., Birt A., Andersen J., Zee B., Paul J., Pecorelli S., Baron B. and McGuire W. (20040408). Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

MLA

Piccart M J, Bertelsen K, Stuart G, Cassidy J, Mangioni C, Simonsen E, James K, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson R, Swenerton K, Trope C, Nardi M, Kaern J, Tumolo S, Timmers P, Roy J-A, Lhoas F, Lidvall B, Bacon M, Birt A, Andersen J, Zee B, Paul J, Pecorelli S, Baron B and McGuire W. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 20040408.